Basilea Pharmaceutica Ltd.

Swiss Biotech Association

Member

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). It focuses on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives.

https://www.basilea.com
+41 61 606 11 11
info_basilea@basilea.com
Dr. Peer Nils Schröder

Location

Grenzacherstrasse 487, 4058 Basel

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2000
Number of employees in Switzerland

150-249

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member

JFG Life Sciences Stiftung der Universität Basel

Our foundation supports the transfer of innovation from medical research to industry, in particular through young entrepreneurship in Switzerland. We invest in companies in Switzerland or abroad that are active in the field of life sciences. We value strong founding teams and high-quality science.
4051 Basel

Member

Swizzard Pharma AG

Headquartered in Zug, Switzerland, Swizzard Pharma AG's mission is to support pharma/biotech companies in setting up a smart & lean Swiss infrastructure. We build on long-term partnership and offer a quality approach to maximize the value of your medical breakthroughs in Switzerland.
6300 Zug

Member